Pacer Advisors’s Twist Bioscience TWST Stock Holding History

Pacer Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70K	Buy	+680	New	+$44.2K	﹤0.01%	1964
2024 Q3	–	Sell	-586	Closed	-$28.9K	–	2700
2024 Q2	$28.9K	Sell	586 -552	-49%	-$22.5K	﹤0.01%	3352
2024 Q1	$39K	Buy	+1,138	New	+$41.1K	﹤0.01%	3269
2021 Q2	–	Sell	-546	Closed	-$68K	–	1557
2021 Q1	$68K	Sell	546 -382	-41%	-$58K	﹤0.01%	1391
2020 Q4	$131K	Sell	928 -1,012	-52%	-$112K	﹤0.01%	1316
2020 Q3	$147K	Buy	+1,940	New	+$121K	﹤0.01%	1213

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Pacer Advisors's TWST Position: Q2 2026 in Review

Pacer Advisors opened a new position in Twist Bioscience (TWST) in Q2 2026: 680 shares worth $70K. The stake represents ﹤0.01% of the portfolio and ranks #1964 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in TWST as recently as Q2 2024.

Pacer Advisors first reported a position in TWST in Q3 2020 and has held it in 6 quarters since. The position peaked at $147K in Q3 2020. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Pacer Advisors held 680 shares of Twist Bioscience worth $70K as of Q2 2026.
Twist Bioscience was a new Pacer Advisors position in Q2 2026.
Twist Bioscience made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #1964 holding.
Pacer Advisors first reported a position in Twist Bioscience in Q3 2020 and has held it in 6 quarters since.
Pacer Advisors's Twist Bioscience position peaked at $147K in Q3 2020.
338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.